Concert Pharmaceuticals Overview

Concert Pharmaceuticals Operating Income

Operating Income for CNCE.

Quarterly Operating Income

$-29606000.00

↑ 10.49% YoY

As of Sep 30, 2022

Annual Operating Income (TTM)

$-68728051.00

↑ 4.04% YoY

Trailing 12 months ending Sep 30, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin